Plexus Corp. (NASDAQ:PLXS) Shares Acquired by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC boosted its position in shares of Plexus Corp. (NASDAQ:PLXSFree Report) by 17.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,779 shares of the technology company’s stock after acquiring an additional 261 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Plexus were worth $278,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Diversified Trust Co grew its holdings in shares of Plexus by 8.3% during the fourth quarter. Diversified Trust Co now owns 3,789 shares of the technology company’s stock worth $593,000 after purchasing an additional 289 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Plexus by 17.2% during the 4th quarter. GAMMA Investing LLC now owns 891 shares of the technology company’s stock worth $139,000 after acquiring an additional 131 shares in the last quarter. Tidal Investments LLC increased its position in shares of Plexus by 102.7% in the third quarter. Tidal Investments LLC now owns 5,723 shares of the technology company’s stock valued at $782,000 after buying an additional 2,899 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Plexus by 0.8% in the third quarter. Geode Capital Management LLC now owns 653,759 shares of the technology company’s stock valued at $89,392,000 after purchasing an additional 4,926 shares in the last quarter. Finally, Disciplined Growth Investors Inc. MN grew its holdings in Plexus by 2.8% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 2,168,512 shares of the technology company’s stock valued at $296,457,000 after buying an additional 59,465 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Insider Buying and Selling

In other news, CFO Patrick John Jermain sold 5,045 shares of the stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $143.13, for a total value of $722,090.85. Following the completion of the sale, the chief financial officer now directly owns 24,602 shares of the company’s stock, valued at $3,521,284.26. This represents a 17.02 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of Plexus stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $165.90, for a total transaction of $497,700.00. Following the sale, the insider now directly owns 5,605 shares of the company’s stock, valued at $929,869.50. This trade represents a 34.86 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,091 shares of company stock worth $5,377,960 in the last three months. 1.76% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on PLXS. StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. KeyCorp began coverage on Plexus in a research note on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Needham & Company LLC upped their price objective on shares of Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a research report on Friday, October 25th. Benchmark lifted their price target on shares of Plexus from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Monday, October 28th. Finally, Stifel Nicolaus lifted their target price on Plexus from $136.00 to $150.00 and gave the stock a “hold” rating in a research report on Tuesday, December 10th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $159.00.

Read Our Latest Stock Analysis on Plexus

Plexus Trading Up 1.5 %

Shares of NASDAQ:PLXS opened at $167.36 on Friday. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. The company’s 50-day moving average price is $161.73 and its 200 day moving average price is $139.62. The company has a market cap of $4.53 billion, a PE ratio of 41.74 and a beta of 0.91. Plexus Corp. has a fifty-two week low of $90.18 and a fifty-two week high of $170.07.

Plexus (NASDAQ:PLXSGet Free Report) last released its earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, beating the consensus estimate of $1.55 by $0.30. The firm had revenue of $1.05 billion for the quarter, compared to analysts’ expectations of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. Plexus’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the company earned $1.44 EPS. Sell-side analysts anticipate that Plexus Corp. will post 6.13 earnings per share for the current year.

About Plexus

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Further Reading

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.